Key Highlights
- Strategists at a major global bank lowered US stocks to neutral from overweight on November 9, 2026, a stance that runs counter to the rally in SPDR S&P 500 ETF (NYSEARCA:SPY).
- Also moved to neutral from overweight is global tech, while the team favored European stocks outside Britain plus global health care, lifting both to overweight.
- The team said positioning might reset lower, potentially into net short levels for indexes such as the Nasdaq, and that Volatility had spread across the market.
- The recommendation followed a selloff that erased roughly USD 3 trillion of value across S&P 500 companies, before the index rose 2.35% on November 9.
What Changed in the Allocation
The move is about emphasis, not a bearish pivot. The strategists still hold positive index targets for next year and stay constructive on artificial intelligence over the long run, but they reduced their tilt toward the US and tech after a sharp mood swing. US equities and global technology both fell to neutral from overweight. The group, meanwhile, boosted European stocks outside the UK to overweight and moved global health care up to overweight from neutral. For those holding SPDR S&P 500 ETF (NYSEARCA:SPY) or similar broad US vehicles, paying a premium for US exposure looks less compelling for now, even though the Long-term Growth case endures. The call came out on the same day the index posted its top gain since April.
Drivers Behind the Tilt Toward Europe
The midterm outcome was the catalyst. A Democratic sweep raised the likelihood of tougher rules on Data Center construction, which hammered the most AI-sensitive stocks and produced the S&P 500's worst week since April 2025. The strategists additionally cited mounting funding costs for AI infrastructure, since firms are borrowing heavily to build data centers while rates are seen rising in December. Europe looks different: its indexes have much smaller AI infrastructure exposure, and the region has historically come through AI-led selloffs in better shape. European markets would also profit more from cheaper oil, a notable point after crude fell over 4% on November 9. Health care earned favor as a defensive group with lower valuations and less dependence on the AI capex cycle.
Interpreting the Call for Portfolio Exposure
A single strategy note does not dictate market direction, but it highlights a wider debate over concentration. The largest American companies now represent a big portion of index value and projected Earnings growth, so any slowdown in AI spending hits broad funds harder than it did before. The counterpoint: earnings at the biggest firms are still resilient, and the November 9 rally suggests buyers are ready to re-enter. Market Participants will monitor the October CPI release, the Fed's December 8 and 9 gathering, Nvidia's November 17 results and any state-level data center rules. These markers will reveal whether the move toward Europe and defensive groups builds momentum or loses steam as the AI trade rebounds.
Where Things Stand
On November 9, 2026, a major bank lowered its ratings on US equities and global technology to neutral, pointing to a possible positioning reset, broad volatility, data center rules after the midterms and AI financing costs. The team also upgraded Europe ex-UK and global health care to overweight. The call reads as a rotation signal rather than a bearish forecast, since year-ahead index targets remain positive.






Please wait processing your request...